1H-imidazo[4,5-c]quinolines
US8895581B2 · kind B2 · utility
9Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2011 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | May 17, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses compounds of general formula (1), wherein the groups R1 to R7, Qa, Qb, L, n and m are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, pharmaceutical preparations containing such compounds and their use as medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.